By mining the genome using our bioinformatics platform we discover and re-purpose natural gene regulatory elements, creating customised gene expression systems to: 1. Improve human health: Creating highly selective and controllable promoters and gene expression cassettes for novel gene and cell therapy systems. Improving the efficiency of biologics production by increasing protein yields in upstream manufacturing processes. 2. Engineer biology: Harnessing synthetic biology to make promoters for a wide array of chassis organisms used in Industrial Biotech. Creating switches and gene circuits that can be employed in the metabolic engineering applications. 3. Enable traits discovery: Designing tissue-selective plant synthetic promoters active across different crop species for Agricultural Biotech applications. Using plant genomics to facilitate the design of environmentally-regulated and pathogen-responsive promoters.
| Website | https://www.chromatinbio.com |
| Employees | 8 (3 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Bioinformatics Platform, Gene Therapy, Genetic Engineering, Drug Discovery, Precision Medicine, Biotechnology, Molecular Biology, Synthetic Biology, Gene Editing, Human Health, Therapeutic Applications, Life Sciences |
Looking for a particular Chromatin Bioscience employee's phone or email?
Michael Roberts is the Founder and CEO of Chromatin Bioscience.
3 people are employed at Chromatin Bioscience.
Chromatin Bioscience is based in Edinburgh, Scotland.